Samuel J. Reich

Insider Reports History

Entity
Individual
Location
Acuity Pharmaceuticals Inc, 3701 Market Street, Philadelphia, PA
Signature
/s/ Samuel J. Reich
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Samuel J. Reich:

Stock Role Class Num Shares Value Price $ Report Date Ownership
SAB Biotherapeutics, Inc. CEO & EXECUTIVE CHAIRMAN, Director Common Stock 548K $482K $0.88 Nov 29, 2023 Via Big Cypress Holdings LLC
SAB Biotherapeutics, Inc. CEO & EXECUTIVE CHAIRMAN, Director Common Stock 219K $193K $0.88 Nov 29, 2023 Direct
SAB Biotherapeutics, Inc. CEO & EXECUTIVE CHAIRMAN, Director Stock Option (right to buy) 35.7K Jul 15, 2024 Direct

Insider Reports Filed by Samuel J. Reich

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SABS SAB Biotherapeutics, Inc. Jul 15, 2024 1 $0 4 Jul 17, 2024 CEO & EXECUTIVE CHAIRMAN, Director
SABS SAB Biotherapeutics, Inc. Feb 21, 2024 1 $0 4 Feb 23, 2024 CEO & EXECUTIVE CHAIRMAN, Director
SABS SAB Biotherapeutics, Inc. Nov 29, 2023 1 $9.84K 4 Nov 30, 2023 Executive Chairman, Director
SABS SAB Biotherapeutics, Inc. Mar 14, 2023 1 $0 4 Mar 16, 2023 Executive Chairman, Director
SABS SAB Biotherapeutics, Inc. Feb 28, 2023 2 $0 4 Mar 2, 2023 Executive Chairman, Director
SABS SAB Biotherapeutics, Inc. Sep 13, 2022 1 $0 4 Sep 15, 2022 Executive Chairman, Director
SABS SAB Biotherapeutics, Inc. May 20, 2022 2 $0 4 May 23, 2022 Executive Chairman, Director
SABS SAB Biotherapeutics, Inc. Mar 16, 2022 1 $0 4 Mar 18, 2022 Executive Chairman, Director
SABS SAB Biotherapeutics, Inc. Nov 17, 2021 1 $0 4 Nov 19, 2021 Executive Chairman, Director
SABS Big Cypress Acquisition Corp. Oct 14, 2021 1 $10.1K 4 Oct 15, 2021 CEO and CFO, Director, 10%+ Owner